Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

Cannabis Law Report

DECEMBER 14, 2021

(“IGC” or the “Company”) today announced positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a proprietary cannabinoid-based investigational new drug candidate for patients who have Alzheimer’s disease. Safety and Tolerability (S&T) was assessed by asking participants to record Adverse Events (AEs).

Clinical Trials 52

Clinical Trials Safety Data Patients 52

The Joint Blog

APRIL 17, 2020

But as an older user-base with more complicated medical conditions continue to grow, it is important to understand how THC could adversely impact other co-administered medications. Medical cannabis is typically prescribed for patients with severe conditions including inflammatory conditions (e.g.,

Events 48

Events THC Chronic Pain Sleep 48

Cannabis Law Report

JUNE 23, 2021

RYAH is pleased to contribute RYAH’s IoT devices and data platform and work with Medicann toward perfecting prescribing practices and dosing regimens,” said Gregory Wagner , CEO of RYAH Group, Inc. With a strong IP portfolio, RYAH gathers deep and insightful data on the complete patient session and formulation life cycle.

Programs 100

Programs Data Events Collective 100

Cannabis Law Report

JUNE 1, 2021

Given the size and scale of the study, RYAH has developed a custom software solution, using OAuth API-integration to protect the privacy of the participants in the study, with the goal of enabling a fully integrated, patient feedback and data collection capability. About RYAH Group, Inc. RYAH Group, Inc.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

SEPTEMBER 22, 2021

Data indicates potential of drug candidate to deliver an extremely potent therapeutic benefit at a very low non-toxic dose. New data will be presented at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Watch how Supera-CBD works. “We

Pharmaceutical 52

Pharmaceutical Data CBD Clinical Trials 52

Cannabis Law Report

JULY 19, 2021

The data from the study is expected to be embedded into the RYAH MD platform, with the goal of enabling healthcare professionals to administer THC, CBD and terpenes in milliliters, which are then expected to automatically be converted into milligrams to allow for a customized, targeted patient inhalation session. “Our billion by 2027.

Therapy 76

Therapy Data Research and Development Events 76

NORML

MARCH 20, 2019

NORML has previously written on the data showing a multi-directional association between cannabis and psychiatric illnesses, and we have cautioned that those predisposed to psychosis or other disorders may be at higher risk for adverse events. But it is not evidence that marijuana in any way causes the condition.

THC 280

THC Data Cannabis Events 280

Cannabis Law Report

DECEMBER 7, 2021

While cannabidiol was associated with a reduction in reported seizure events (RR?=?0.59, A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events. Adverse mental events were reported as well, however, more research should be performed to assess well this outcome. 1.69, 95% CI [1.20–2.36])

Safety 52

Safety Cannabinoids Events Data 52

Canna Law Blog

MARCH 30, 2022

Data reveal a concerning increase in violent crime in many U.S. This includes both steps to prevent or mitigate the risks of criminal acts as well as protections in the event that a crime does occur. As noted above, dangerous physical conditions on the property raise the potential for liability and should be regularly inspected for.

Business 83

Business Policy Events Conditions 83

Cannabis Law Report

JUNE 16, 2021

This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol. Training will be provided within the research program for licensed practitioners to assess the safety of psychedelic medicines and to classify and report positive and adverse events.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

DECEMBER 9, 2021

“Partnering with Fyllo reinforces our commitment to delivering innovative data solutions designed to enhance our clients’ audience reach strategies,” said Jay Baum , Chief Commercial Officer at Tremor Video. Learn more about Tremor Video’s data-driven audience solutions at www.tremorvideo.com. Traditional segments (e.g.

CBD 52

CBD Data Compliance Compliance 52

Veriheal

JULY 12, 2021

According to the American Psychiatric Association , PTSD is a “psychiatric disorder that may occur in people who have experienced or witnessed a traumatic event such as natural disaster, as a serious accident, a terrorist act, war/combat or rape or who have been threatened with death, sexual violence or serious injury”.

Treatment 104

Treatment Sleep Clinical Trials Data 104

Cannabis Law Report

JUNE 16, 2021

Genetic Screening Platform Technology and Data to Strengthen Entheon’s Psychedelic-Assisted Protocols. Lobo brings a highly experienced and specialized team of technology experts in the fields of genetics, diagnostics, data and analytics, as well as a fully operational 5,000 sq. Vancouver, British Columbia–(Newsfile Corp.

Research and Development 105

Research and Development Data Conditions Events 105

Cannabis Law Report

AUGUST 27, 2021

“This impressive group represents well-known leaders in the psychedelic and addiction fields and will help usher in a greater understanding of the science and data behind what we expect to be the most effective treatments for many mental health conditions ever available.”.

Research and Development 98

Research and Development Treatment Media Medicine 98

Cannabis Law Report

JULY 29, 2021

Our evidence-based scientific approach has enabled us to develop a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. Forward-looking statements. Some statements in this release may contain forward-looking information.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

The Cannigma

JULY 17, 2022

You don’t need a medical condition or a paid subscription – the ROC serves curious consumers, medical professionals, and anyone else who is looking to better their life through cannabinoid therapies. The advice and suggestions are based on data, including the results from ROC’s own cannabis research registry. The Realm of Caring.

Advocacy 120

Advocacy Education Events Epilepsy 120

Cannabis Law Report

JULY 6, 2021

High Tide gains access to Daily High Club’s over 15,000 subscription box members who are ideal customers for High Tide to potentially launch cannabis subscription boxes in the event of U.S. 1 As of June 21st, 2021, based on analytics data provided by Alexa Internet, Inc. Traffic data provided by Google Analytics.

Consumption 116

Consumption Retail Events Media 116

Veriheal

MAY 30, 2023

Cancer Pain Relief With Cannabis: What the New Study Shows Utilizing data from the Quebec Cannabis Registry in Canada, researchers sought to examine the safety and effectiveness of cannabis in addressing cancer pain. Always consult a physician before making any decision on the treatment of a medical condition.

Medicine 98

Medicine Treatment Patients Data 98

Cannabis Law Report

JULY 30, 2021

SOL Global’ s largest core holdings have achieved liquidity events and produced positive returns on investment. The Company believes this non-IFRS measure does not only provide management with comparable financial data for internal financial analysis but also provides meaningful supplemental information to investors. at May 31, 2020.

Events 105

Events Business Media Conditions 105

Cannabis Law Report

NOVEMBER 16, 2021

Previously (at age 18), Pep founded and was the Chairman and CEO of Fever ( www.feverup.com ), the world’s leading event discovery platform. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information.

Data 52

Data Events Research and Development Business 52

The Blunt Truth

MARCH 10, 2020

CBD continues to flourish in the markets despite lack of federal regulations, and we’ve identified some significant events that indicate there’s no sign it’s stopping. Manufacturers are responsible for certifying records, including all product data, which includes, for example, information on formulation, labeling, and DEA Schedule.

CBD 99

CBD Topical Agriculture Food 99

Illinois News Joint

MAY 12, 2023

A third item states that, “The Department shall authorize a dispensing organization that has been unable to find a suitable location within the BLS Region in which it was awarded a license to transfer its Conditional Adult Use Dispensing Organization License to another BLS Region specified by the Department.” “BLS

Packaging 100

Packaging Agriculture Cultivation Cannabis 100

Cannabis Law Report

AUGUST 10, 2021

The Company disclaims any obligation to update developments of these risk factors or to announce publicly any revision to any of the forward-looking statements contained in this release, or to make corrections to reflect future events or developments. federal securities laws that are subject to risks and uncertainties.

Collective 105

Collective Hydroponic Events Business 105

Cannabis Law Report

JULY 9, 2021

The Horizons ETFs product family includes a broadly diversified range of solutions for investors of all experience levels to meet their investment objectives in a variety of market conditions. Horizons ETFs has over $19 billion of assets under management and 95 ETFs listed on major Canadian stock exchanges.

Data 105

Data Clinical Trials Decriminalization Hemp 105

The Joint Blog

DECEMBER 20, 2020

“Respondents reported a median score of 90 on a zero to 100-point scale in response to the question, “How does cannabis affect your conditions or symptoms overall?” Materials and Methods: A cross-sectional online survey of those using cannabis for health-related conditions run between May and July 2019.

Sleep 49

Sleep Data Pharmaceutical Marijuana 49

Cannabis Law Report

AUGUST 17, 2021

Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced topline data from its open-label Phase 2 trial evaluating safety and efficacy of adjunctive oral ganaxolone treatment in 23 patients with seizures associated with tuberous sclerosis complex (TSC).

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Cannabis Law Report

SEPTEMBER 24, 2021

Having a presence and booth at this large-scale event will allow us to build our brand in this market sector, expand relationships with existing customers, and show our services to future clients. MJBizCon is expecting over 10,000 people at this year’s event, including growers, services providers, and investors.

Agriculture 52

Agriculture Events Business Education 52

Illinois News Joint

JANUARY 5, 2023

In addition to three social equity adult use cannabis dispensaries that opened in 2022, 189 other conditional licensees are in the process of receiving full dispensary license from IDFPR. Our data from 2022 shows that we are well on our way towards making that idea a reality,” said Governor JB Pritzker.

Dispensary 77

Dispensary Recreational Cannabis Collective 77

Cannabis Law Report

JUNE 28, 2021

Based on government agency data, when viewed collectively, Ionic Brands manufacturing partners’ amount to the fifth-largest wholesale operator in Washington by revenue for the period of 2020. Actual results could be affected by subsequent events or determinations. Chairman & Chief Executive Officer. 1.253.248.7927.

Business 95

Business Supply Chain Data Concentrates 95

Cannabis Law Report

JUNE 1, 2021

The acquisition is expected to close in Q3 2021, subject to closing conditions and covenants customary for this type of transaction, including, without limitation, obtaining MED and local licensing approval. The Company is committed to unlocking the full potential of the cannabis plant to improve the human condition. About Schwazze.

Seed-To-Sale 85

Seed-To-Sale Cultivation Events Strains 85

Cannabis Law Report

OCTOBER 22, 2021

–The Company expects to hold a Research & Development event to review,these breakthrough findings in Q4 2021 that will be open to the public, shareholders, analysts and the media– TORONTO, CANADA – October 19, 2021 – Cybin Inc.

Research and Development 52

Research and Development Safety Media Data 52

Cannabis Law Report

JULY 28, 2021

Active research includes applications of machine learning and data mining as a member of the University of Alberta computational psychiatry group. These statements relate to future events or future performance. Cautionary Note on Forward-Looking Information. This news release contains forward?looking looking statements and forward?looking

Research and Development 105

Research and Development Events Media Data 105

Illinois News Joint

FEBRUARY 7, 2023

The Disparity and Availability Study’s purpose is to collect and analyze data and will report on whether discrimination exists in the Illinois cannabis industry. To learn about cannabis-friendly events in Illinois, visit here. The finished results of the report will be given to the Illinois General Assembly and Governor. Constitution.

Agriculture 75

Agriculture Cannabis Policy Dispensary 75

Cannabis Law Report

MARCH 3, 2022

A representative of the Impact Forum told Marijuana Moment in an email that the event “is private and we do not issue transcripts, audio or video.”. “No Last week, at the Impact Forum event , the former president reportedly stressed the “need to have a national standard of the THC count of these products and what the tests show.”.

Media 52

Media CBD Events THC 52

Cannabis Law Report

JUNE 2, 2021

“Each of the six locations has been issued a conditional RSA and work will begin immediately upon closing the Transactions to convert the stores to the Value Buds banner, and to obtain approval to open from the AGCO, just in time to take full advantage of the anticipated summer demand.” million in cash and $1.1

Business 105

Business Hybrid Retail Conditions 105

Cannabis Law Report

OCTOBER 6, 2021

Flora Pharma will seek to identify scientific gaps in the cannabis industry and ultimately work to translate that to pharmaceutical cannabis products backed by data. The immediate next steps are to submit data for ethics committee review and approval whereupon acceptance, further details will be provided. “A

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Events 52